COMMUNIQUÉS West-GlobeNewswire

Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study
09/10/2018
Data published in the American Journal of Hematology show more than twice as many patients taking crizanlizumab did not experience a disease-related pain crisis (also called vaso-occlusive crisis, or VOC) vs placebo [...]
Acura Pharmaceuticals, Inc. Restructures Debt Obligations
09/10/2018
PALATINE, Ill., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) , a specialty pharmaceutical company focused on innovating abuse deterrent drugs , today announced that on October 5, 2018 we [...]
Dragon Jade to Restructure Montrose Group Acquisition
09/10/2018
HONG KONG, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today announced that it will restructure its [...]
ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
09/10/2018
Abstract featuring-IMPLANT2 data awarded Prize Paper by Society for Assisted Reproductive Technology (SART) Nolasiban treatment shown to significantly increase Live Birth Rate (LBR) in randomized clinical trial of [...]
DiaSorin and Meridian Enter Into a Strategic Collaboration to Sell Helicobacter Pylori Stool Antigen Test in the United States and in the United Kingdom
09/10/2018
SALUGGIA, Italy and CINCINNATI, Oct. 09, 2018 (GLOBE NEWSWIRE) -- DiaSorin S.p.A. (FTSE Italy Mid Cap: DIA) and Meridian Bioscience, Inc . (NASDAQ:VIVO) today announced that DiaSorin Inc., a subsidiary of DiaSorin S.p.A [...]
Guardant Health Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
09/10/2018
REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH) today announced the closing of its initial public offering of 14,375,000 shares of common stock, which includes the exercise in [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/10/2018
MENLO PARK, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at ASN Kidney Week 2018
09/10/2018
REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, will present new data on Veltassa® (patiromer) at the American Society of Nephrology (ASN) Kidney Week, the world’s [...]
Athersys to Host Third Quarter Financial Results Call
09/10/2018
CLEVELAND, Ohio, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) will release its third quarter 2018 financial results at approximately 4:00 p.m. Eastern Time on Tuesday, November 6th, 2018, and will [...]
How to Use Bleach Baths to Help Manage Eczema Flares; American Academy of Dermatology
09/10/2018
ROSEMONT, Ill., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Although hot water and bubble baths may sound relaxing to many, for those with atopic dermatitis, this can have the opposite effect, causing dry, scaly, red patches to [...]
Avadim Health, Inc. Announces Growth Capital Investment of $60 Million
09/10/2018
ASHEVILLE, N.C., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Avadim Health, Inc. (“Avadim Health”), the Bionome Therapies TM life sciences company, is pleased to announce today that it has closed a debt financing round with gross [...]
Project HOPE Honors Merck for Impact in Global Health at 60th Anniversary Gala
09/10/2018
Former First Lady Laura Bush Delivers Keynote Address Millwood, VA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Project HOPE honors its longest serving corporate partner, Merck and Co., Inc., for its outstanding contributions in [...]
CTD Holdings to Present at BioFlorida Conference with update on Clinical Program Using Cyclodextrins to treat diseases with Unmet Medical Needs
09/10/2018
ALACHUA, Fla., Oct. 09, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biopharmaceutical company that develops cyclodextrin-based products for the treatment of disease with unmet needs, [...]
DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company
09/10/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
09/10/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
CEO Fred Angelopoulos of Maverick Technology Solutions, maker of Industry Leading ROSINBOMB Line of Products, featured at CWCB Expo LA
09/10/2018
Fred Angelopoulos was a featured speaker at the recent CWCB Expo in Los Angeles RENO, Nev., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC: MVRK ), innovator and manufacturer of the ROSINBOMB line [...]
Pathway Health Selected as Training and Implementation Partner for the Consonus Co-Pilot Application
09/10/2018
LAKE ELMO, Minn. and MILWAUKIE, Ore., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Pathway Health has been selected by Consonus Healthcare as its implementation, training and ongoing support services partner for its new app, [...]
Imprivata Extends Secure Medical Device Access to Howard Medical Storage Carts
09/10/2018
Technology integration will be on display at Cerner Health Conference LEXINGTON, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced a collaboration with Howard [...]
Lixte Biotechnology Files an IND with the FDA to Conduct a Phase 1b/2 Trial of LB-100 in Patients with Myelodysplastic Syndrome at Moffitt Cancer Center
09/10/2018
EAST SETAUKET, NY , Oct. 09, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) announced that it has submitted an IND to the FDA to conduct a Phase 1b/2 trial of the safety and therapeutic [...]

Pages